FDA Panel: Vaccine Protects Against a Cancer

An FDA panel recommends the approval of a vaccine to prevent cervical cancer, the second-most deadly cancer for women. The new vaccine, made by Merck, could reduce the number of cervical cancer cases world wide by about two-thirds.

The vaccine protects against the most carcinogenic forms of the human papilloma virus, or HPV, which causes cervical cancer. The federal review panel was unanimous in its approval of the vaccine.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.